---
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/276583583.md"
description: "Novo Nordisk's U.S. stock pre-market fell 11%, while Eli Lilly rose over 4% in pre-market trading. Novo Nordisk's CagriSema performed worse than Eli Lilly's Zepbound in trials"
datetime: "2026-02-23T09:39:26.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/276583583.md)
  - [en](https://longbridge.com/en/news/276583583.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/276583583.md)
---

# 

Novo Nordisk's U.S. stock pre-market fell 11%, while Eli Lilly rose over 4% in pre-market trading. Novo Nordisk's CagriSema performed worse in trials compared to Eli Lilly's Zepbound

### Related Stocks

- [IXJ.US](https://longbridge.com/en/quote/IXJ.US.md)
- [NVO.US](https://longbridge.com/en/quote/NVO.US.md)
- [SBIO.US](https://longbridge.com/en/quote/SBIO.US.md)
- [LLYX.US](https://longbridge.com/en/quote/LLYX.US.md)
- [ELIS.US](https://longbridge.com/en/quote/ELIS.US.md)
- [FBT.US](https://longbridge.com/en/quote/FBT.US.md)
- [BBH.US](https://longbridge.com/en/quote/BBH.US.md)
- [XBI.US](https://longbridge.com/en/quote/XBI.US.md)
- [PBE.US](https://longbridge.com/en/quote/PBE.US.md)
- [VHT.US](https://longbridge.com/en/quote/VHT.US.md)
- [LLY.US](https://longbridge.com/en/quote/LLY.US.md)
- [IBB.US](https://longbridge.com/en/quote/IBB.US.md)
- [IHE.US](https://longbridge.com/en/quote/IHE.US.md)
- [XLV.US](https://longbridge.com/en/quote/XLV.US.md)

## Related News & Research

- [Behzad Aghazadeh Holds Board Seat at Scribe Therapeutics with 16.37% Stake](https://longbridge.com/en/news/294437888.md)
- [Lilly, Resilience to invest $750 million in US drug manufacturing expansion](https://longbridge.com/en/news/294370095.md)
- [Novo Nordisk seeks preliminary injunction against Lilly weight-loss ads](https://longbridge.com/en/news/293725132.md)
- [First Trust Advisors LP Acquires 1,305 Shares of Eli Lilly and Company $LLY](https://longbridge.com/en/news/293719299.md)
- [HBM Healthcare swings to CHF 238 million Q1 FY27 profit; NAV per share rises 13%](https://longbridge.com/en/news/293701781.md)